Our Team
Our team consists of about 25 scientists who between us, have extensive experience in drug discovery. We are experts in the fields of biology, chemistry, preclinical and clinical development, and project and alliance management. Our multidisciplinary specialists also have commercial and investment responsibility, allowing for a close working relationship scientifically and operationally with your organization.
The ceedd is based in two geographical centers in the U.K. and the U.S. This allows for closer networking with you and a greater understanding of your local environment, enabling faster decision making across all the stages of our interactions. When your company chooses to work with us, you will work with a specially tailored team with one dedicated, expert point of contact. This not only facilitates consistency and ease of working, but also allows for greater efficiency and synergy between the two parties, producing a strong and more productive alliance.
Team Bios
Click on an image below to view more details.
Michelle Dipp, M.D., Ph.D.
Senior Vice President, ceedd
Anna Maroney, Ph.D.
Vice President, Head of U.S. ceedd
Rob Aboud, J.D., M.S.
Vice President, Head, Global Operations & Strategy Development
David Donabedian, Ph.D., M.B.A.
Vice President of Strategic Alliances, U.S. ceedd
Mustafa Noor, M.D., M.Sc.
Vice President, Head of Clinical Development
Deven Shah, Ph.D.
Director of Preclinical Development
Connie Erickson-Miller, Ph.D.
Research Director
John Cantello, Ph.D.
Vice President, Global New Deal Strategy and Development
Declan Jones, Ph.D.
Head of European ceedd
Andrew A. Parsons, Ph.D.
Vice President, Head of Preclinical Development
Bernadette Cummins, Ph.D.
Head of Commercial
Nicki Thompson, Ph.D.
Director, Scientific Opportunities
Rick Cousins, Ph.D.
Research Director
George Stroup, M.S.
Alliance and Project Leader
